# Vsee Health, Inc.: financial statements, quarterly

VSEE · CIK 1864531 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vsee.md) · [Financials](/companies/vsee/financials.md) · [Filings](/companies/vsee/filings.md) · [Insiders](/companies/vsee/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vsee/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.4](/filings/0001558370-25-011815.md) | [1.5 d](/filings/0001558370-25-011815.md) | [1.6](/filings/0001185185-25-001448.md) | [1.7](/filings/0001185185-25-001818.md) | [3.4](/filings/0001185185-25-001744.md) | [3.7 d](/filings/0001185185-26-001202.md) | [3.3](/filings/0001185185-26-001883.md) | [1.1](/filings/0001185185-26-003549.md) | [4.0](/filings/0001185185-25-001744.md) | [3.9 d](/filings/0001185185-26-001202.md) | [3.2](/filings/0001185185-26-001883.md) | [1.6](/filings/0001185185-26-003549.md) |
| Cost of revenue | $m | [0.5](/filings/0001558370-24-015753.md) | [0.4 d](/filings/0001558370-25-011815.md) | [0.4](/filings/0001185185-25-001448.md) | [0.9](/filings/0001185185-25-001818.md) | [0.6](/filings/0001185185-25-001744.md) | [1.4 d](/filings/0001185185-26-001202.md) | [1.5](/filings/0001185185-26-001883.md) | [0.4](/filings/0001185185-26-003549.md) | [1.9](/filings/0001185185-25-001744.md) | [2.1 d](/filings/0001185185-26-001202.md) | [2.0](/filings/0001185185-26-001883.md) | [1.4](/filings/0001185185-26-003549.md) |
| Gross profit | $m | [1.0](/filings/0001558370-25-011815.md) | [1.1 d](/filings/0001558370-25-011815.md) | [1.2](/filings/0001185185-25-001448.md) | [0.8](/filings/0001185185-25-001818.md) | [2.8](/filings/0001185185-25-001744.md) | [2.4 d](/filings/0001185185-26-001202.md) | [1.9](/filings/0001185185-26-001883.md) | [0.6](/filings/0001185185-26-003549.md) | [2.1](/filings/0001185185-25-001744.md) | [1.8 d](/filings/0001185185-26-001202.md) | [1.2](/filings/0001185185-26-001883.md) | [0.2](/filings/0001185185-26-003549.md) |
| Operating income | $m | [(0.4)](/filings/0001558370-25-011815.md) | [(0.1) d](/filings/0001558370-25-011815.md) | [0.1](/filings/0001185185-25-001448.md) | [(0.9)](/filings/0001185185-25-001818.md) | [(58.3)](/filings/0001185185-25-001744.md) | [(3.0) d](/filings/0001185185-26-001202.md) | [(1.8)](/filings/0001185185-26-001883.md) | [(1.6)](/filings/0001185185-26-003549.md) | [(2.1)](/filings/0001185185-25-001744.md) | [(3.4) d](/filings/0001185185-26-001202.md) | [(3.0)](/filings/0001185185-26-001883.md) | [(2.7)](/filings/0001185185-26-003549.md) |
| Interest expense | $m | [0.0](/filings/0001558370-24-015753.md) | [0.0 d](/filings/0001558370-25-011815.md) | [0.0](/filings/0001185185-25-001448.md) | [0.3](/filings/0001185185-25-001818.md) | [0.1](/filings/0001185185-25-001744.md) | [(0.3) d](/filings/0001185185-26-001202.md) | [0.0](/filings/0001185185-26-001883.md) | [0.2](/filings/0001185185-26-003549.md) | [0.8](/filings/0001185185-25-001744.md) | [1.1 d](/filings/0001185185-26-001202.md) | [0.1](/filings/0001185185-26-001883.md) | [0.0](/filings/0001185185-26-003549.md) |
| Income tax | $m | [(0.2)](/filings/0001558370-24-015753.md) | [2.4 d](/filings/0001558370-25-011815.md) | [0.0](/filings/0001185185-25-001448.md) | [(1.7)](/filings/0001185185-25-001818.md) | [0.0](/filings/0001185185-25-001744.md) | [0.0 d](/filings/0001185185-26-001202.md) | [0.0](/filings/0001185185-26-001883.md) | [0.0](/filings/0001185185-26-003549.md) | [0.0](/filings/0001185185-25-001744.md) | [(0.0) d](/filings/0001185185-26-001883.md) | [0.0](/filings/0001185185-26-001883.md) | [(0.0)](/filings/0001185185-26-003549.md) |
| Net income | $m | [(0.2)](/filings/0001558370-25-011815.md) | [(2.5) d](/filings/0001558370-25-011815.md) | [0.1](/filings/0001185185-25-001448.md) | [(0.6)](/filings/0001185185-25-001818.md) | [(53.9)](/filings/0001185185-25-001744.md) | [(3.2) d](/filings/0001185185-26-001202.md) | [(4.0)](/filings/0001185185-26-001883.md) | [(2.6)](/filings/0001185185-25-001818.md) | [(0.3)](/filings/0001185185-25-001744.md) | [(7.9) d](/filings/0001185185-26-001202.md) | [(2.6)](/filings/0001185185-26-001883.md) | [(1.7) d](/filings/0001185185-26-003549.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001558370-25-011815.md) | not reported | [0.01](/filings/0001185185-25-001448.md) | [(0.12)](/filings/0001185185-25-001818.md) | [(3.58)](/filings/0001185185-25-001744.md) | not reported | [(0.24)](/filings/0001185185-26-001883.md) | [(0.16)](/filings/0001185185-25-001818.md) | [(0.02)](/filings/0001185185-25-001744.md) | not reported | [(0.05)](/filings/0001185185-26-001883.md) | not reported |
| Basic EPS | $ per share | [(0.02)](/filings/0001558370-25-011815.md) | not reported | [0.01](/filings/0001185185-25-001448.md) | [(0.12)](/filings/0001185185-25-001818.md) | [(3.58)](/filings/0001185185-25-001744.md) | not reported | [(0.24)](/filings/0001185185-26-001883.md) | [(0.16)](/filings/0001185185-25-001818.md) | [(0.02)](/filings/0001185185-25-001744.md) | not reported | [(0.05)](/filings/0001185185-26-001883.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001104659-23-119930.md) | [0.1](/filings/0001558370-25-011815.md) | [0.0](/filings/0001410578-24-000845.md) | [1.1](/filings/0001558370-24-012936.md) | [2.3](/filings/0001558370-24-015753.md) | [0.3](/filings/0001185185-26-001202.md) | [0.4](/filings/0001185185-25-001448.md) | [0.3](/filings/0001185185-25-001818.md) | [0.5](/filings/0001185185-25-001744.md) | [5.1](/filings/0001185185-26-003549.md) | [1.3](/filings/0001185185-26-001883.md) | [0.5](/filings/0001185185-26-003549.md) |
| Current assets | $m | [0.0](/filings/0001104659-23-119930.md) | [0.8](/filings/0001558370-25-011815.md) | [0.0](/filings/0001410578-24-000845.md) | [3.1](/filings/0001185185-25-001818.md) | [4.4](/filings/0001185185-25-001744.md) | [3.0](/filings/0001185185-26-001202.md) | [3.1](/filings/0001185185-25-001448.md) | [2.6](/filings/0001185185-25-001818.md) | [3.7](/filings/0001185185-25-001744.md) | [8.4](/filings/0001185185-26-003549.md) | [4.8](/filings/0001185185-26-001883.md) | [3.3](/filings/0001185185-26-003549.md) |
| Total assets | $m | [8.1](/filings/0001104659-23-119930.md) | [0.8](/filings/0001558370-25-011815.md) | [1.4](/filings/0001410578-24-000845.md) | [78.6](/filings/0001185185-25-001818.md) | [22.3](/filings/0001185185-25-001744.md) | [20.0](/filings/0001185185-26-001202.md) | [19.4](/filings/0001185185-25-001448.md) | [18.2](/filings/0001185185-25-001818.md) | [18.7](/filings/0001185185-25-001744.md) | [22.4](/filings/0001185185-26-003549.md) | [19.0](/filings/0001185185-26-001883.md) | [16.7](/filings/0001185185-26-003549.md) |
| Current liabilities | $m | [5.0](/filings/0001558370-25-011815.md) | [5.1](/filings/0001558370-25-011815.md) | [9.0](/filings/0001410578-24-000845.md) | [24.1](/filings/0001185185-25-001818.md) | [20.2](/filings/0001185185-25-001744.md) | [19.0](/filings/0001185185-26-001202.md) | [22.0](/filings/0001185185-25-001448.md) | [23.1](/filings/0001185185-25-001818.md) | [23.4](/filings/0001185185-25-001744.md) | [16.2](/filings/0001185185-26-003549.md) | [11.8](/filings/0001185185-26-001883.md) | [8.1](/filings/0001185185-26-003549.md) |
| Total liabilities | $m | [5.0](/filings/0001558370-25-011815.md) | [5.1](/filings/0001558370-25-011815.md) | [5.6](/filings/0001185185-25-001448.md) | [25.5](/filings/0001185185-25-001818.md) | [21.4](/filings/0001185185-25-001744.md) | [20.0](/filings/0001185185-26-001202.md) | [22.9](/filings/0001185185-25-001448.md) | [23.9](/filings/0001185185-25-001818.md) | [24.3](/filings/0001185185-25-001744.md) | [17.0](/filings/0001185185-26-003549.md) | [12.7](/filings/0001185185-26-001883.md) | [9.1](/filings/0001185185-26-003549.md) |
| Long-term debt | $m | not reported | [0.2](/filings/0001558370-25-011815.md) | not reported | [0.6](/filings/0001558370-24-012936.md) | [0.6](/filings/0001558370-24-015753.md) | [0.6](/filings/0001185185-26-001202.md) | [0.6](/filings/0001185185-25-001448.md) | [0.6](/filings/0001185185-25-001818.md) | [0.6](/filings/0001185185-25-001744.md) | [0.6](/filings/0001185185-26-003549.md) | [0.8](/filings/0001185185-26-001883.md) | [0.8](/filings/0001185185-26-003549.md) |
| Current portion of debt | $m | not reported | [0.2](/filings/0001558370-25-011815.md) | not reported | [0.9](/filings/0001558370-24-012936.md) | [0.4](/filings/0001558370-24-015753.md) | [0.4](/filings/0001185185-26-001202.md) | [1.1](/filings/0001185185-25-001448.md) | [1.5](/filings/0001185185-25-001818.md) | [1.9](/filings/0001185185-25-001744.md) | [0.9](/filings/0001185185-26-003549.md) | [0.5](/filings/0001185185-26-001883.md) | [0.3](/filings/0001185185-26-003549.md) |
| Shareholders' equity | $m | [(9.1)](/filings/0001104659-23-119930.md) | [(12.3)](/filings/0001410578-24-000845.md) | [(13.2)](/filings/0001410578-24-000845.md) | [53.1](/filings/0001185185-25-001818.md) | [0.9](/filings/0001185185-25-001744.md) | [(0.0)](/filings/0001185185-25-001818.md) | [(3.5)](/filings/0001185185-25-001448.md) | [(5.7)](/filings/0001185185-25-001818.md) | [(5.6)](/filings/0001185185-25-001744.md) | [5.5](/filings/0001185185-26-003549.md) | [6.3](/filings/0001185185-26-003549.md) | [7.6](/filings/0001185185-26-003549.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(48.8) d](/filings/0001558370-24-015753.md) | [(109) d](/filings/0001558370-25-011815.md) | [579](/filings/0001185185-25-001448.md) | [(3,174) d](/filings/0001185185-25-001818.md) | [(221) d](/filings/0001185185-25-001744.md) | [(2,974) d](/filings/0001185185-26-001202.md) | [(440)](/filings/0001185185-26-001883.md) | [(325) d](/filings/0001185185-26-003549.md) | [(755) d](/filings/0001185185-25-001744.md) | [(1,926) d](/filings/0001185185-26-001202.md) | [(2,452)](/filings/0001185185-26-001883.md) | [(1,174) d](/filings/0001185185-26-003549.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001558370-24-015753.md) | [1.6 d](/filings/0001558370-25-011815.md) | [8.7](/filings/0001185185-25-001448.md) | [36.8 d](/filings/0001185185-25-001818.md) | [5.0 d](/filings/0001185185-25-001744.md) | [4.8 d](/filings/0001185185-26-001202.md) | [11.9](/filings/0001185185-26-001883.md) | [(11.9) d](/filings/0001185185-26-003549.md) | [22.8 d](/filings/0001185185-25-001744.md) | [7.2 d](/filings/0001185185-26-001202.md) | [26.8](/filings/0001185185-26-001883.md) | [73.2 d](/filings/0001185185-26-003549.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [5.2 d](/filings/0001185185-26-001202.md) | [0.0](/filings/0001185185-26-001883.md) | [0.0 d](/filings/0001185185-26-003549.md) | [0.0 d](/filings/0001185185-25-001744.md) | [0.0 d](/filings/0001185185-26-001202.md) | [50.0](/filings/0001185185-26-001883.md) | [0.0 d](/filings/0001185185-26-003549.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.9](/filings/0001104659-23-119930.md) | [4.2](/filings/0001410578-24-000845.md) | [4.6](/filings/0001558370-24-012936.md) | [10.0](/filings/0001558370-24-015753.md) | [4.6](/filings/0001185185-25-001448.md) | [5.3](/filings/0001185185-25-001818.md) | [15.1](/filings/0001185185-25-001744.md) | [16.3](/filings/0001185185-26-001883.md) | [16.4](/filings/0001185185-26-003549.md) | [16.5](/filings/0001185185-25-001744.md) | [47.9](/filings/0001185185-26-001883.md) | [53.7](/filings/0001185185-26-003549.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,679,813 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001185185-26-003549.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.